BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6652344)

  • 1. Glucocorticoid protection against PAF-acether toxicity in mice.
    Myers A; Ramey E; Ramwell P
    Br J Pharmacol; 1983 Jun; 79(2):595-8. PubMed ID: 6652344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paf-acether-induced death in mice: involvement of arachidonate metabolites and beta-adrenoceptors.
    Criscuoli M; Subissi A
    Br J Pharmacol; 1987 Jan; 90(1):203-9. PubMed ID: 2880624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The platelet-independent release of thromboxane A2 by Paf-acether from guinea-pig lungs involves mechanisms distinct from those for leukotriene.
    Lefort J; Rotilio D; Vargaftig BB
    Br J Pharmacol; 1984 Jul; 82(3):565-75. PubMed ID: 6430375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of indomethacin and dazoxiben on intravascular platelet aggregation in the anaesthetized rabbit.
    Honey AC; Lad N; Tuffin DP
    Thromb Haemost; 1986 Aug; 56(1):80-5. PubMed ID: 3775692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of serum albumin, indomethacin and histamine H1-antagonists on Paf-acether-induced inflammatory responses in the skin of experimental animals and man.
    Archer CB; MacDonald DM; Morley J; Page CP; Paul W; Sanjar S
    Br J Pharmacol; 1985 May; 85(1):109-13. PubMed ID: 2862936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between local inflammatory and systemic haematological effects of PAF-acether in the rat.
    Martins MA; Silva PM; Castro HC; Neto F; Lima MC; Cordeiro RS; Vargaftig BB
    Eur J Pharmacol; 1987 Apr; 136(3):353-60. PubMed ID: 3609124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial characterization of the embryo-derived platelet-activating factor in mice.
    O'Neill C
    J Reprod Fertil; 1985 Nov; 75(2):375-80. PubMed ID: 4067921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological investigation of the mechanisms of platelet-activating factor induced mortality in the mouse.
    Young JM; Maloney PJ; Jubb SN; Clark JS
    Prostaglandins; 1985 Oct; 30(4):545-51. PubMed ID: 4081060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAF-acether-induced plasma exudation in rat skin is independent of platelets and neutrophils.
    Pirotzky E; Page CP; Roubin R; Pfister A; Paul W; Bonnet J; Benveniste J
    Microcirc Endothelium Lymphatics; 1984 Feb; 1(1):107-22. PubMed ID: 6546141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-activating factor-acether-induced relaxation of guinea pig airway muscle: role of prostaglandin E2 and the epithelium.
    Brunelleschi S; Haye-Legrand I; Labat C; Norel X; Benveniste J; Brink C
    J Pharmacol Exp Ther; 1987 Oct; 243(1):356-63. PubMed ID: 3478474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation.
    Fouque F; Vargaftig BB
    Br J Pharmacol; 1984 Nov; 83(3):625-33. PubMed ID: 6439269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of PAF-acether in the anaphylactic shock in the rat.
    Damas J
    J Lipid Mediat; 1989; 1(3):161-70. PubMed ID: 2519891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological modulation of Paf-induced rat pleurisy and its role in inflammation by zymosan.
    Martins MA; Silva PM; Faria Neto HC; Bozza PT; Dias PM; Lima MC; Cordeiro RS; Vargaftig BB
    Br J Pharmacol; 1989 Feb; 96(2):363-71. PubMed ID: 2924083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of prostaglandins and PG-analogues on the mortality of PAF-acether in mice and the TXB2 release from human granulocytes.
    Becker K; Förster W
    Biomed Biochim Acta; 1988; 47(10-11):S169-72. PubMed ID: 3248104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human platelet aggregation and release reaction induced by platelet activating factor (PAF-acether)--effects of acetylsalicylic acid and external ionized calcium.
    Cattaneo M; Canciani MT; Mannucci PM
    Thromb Haemost; 1985 Apr; 53(2):221-4. PubMed ID: 3927505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azelastine, a new antiallergic/antiasthmatic agent, inhibits PAF-acether-induced platelet aggregation, paw edema and bronchoconstriction.
    Achterrath-Tuckermann U; Weischer CH; Szelenyi I
    Pharmacology; 1988; 36(4):265-71. PubMed ID: 3380879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential release of tumour necrosis factor, platelet activating factor and eicosanoids during endotoxin shock in anaesthetized pigs: protective effects of indomethacin.
    Mózes T; Zijlstra FJ; Heiligers JP; Tak CJ; Ben-Efraim S; Bonta IL; Saxena PR
    Br J Pharmacol; 1991 Nov; 104(3):691-9. PubMed ID: 1797328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE.
    Mencia-Huerta JM; Lewis RA; Razin E; Austen KF
    J Immunol; 1983 Dec; 131(6):2958-64. PubMed ID: 6315819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of the inflammatory effects of platelet-activating factor by cyclo-oxygenase inhibitors.
    Vargaftig BB; Ferreira SH
    Braz J Med Biol Res; 1981 Jul; 14(2-3):187-9. PubMed ID: 6802210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of platelet-activating factor on the release of arachidonic acid and prostaglandins by rabbit iris smooth muscle. Inhibition by calcium channel antagonists.
    Yousufzai SY; Abdel-Latif AA
    Biochem J; 1985 Jun; 228(3):697-706. PubMed ID: 3927898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.